Literature DB >> 16314477

P-selectin can support both Th1 and Th2 lymphocyte rolling in the intestinal microvasculature.

Claudine S Bonder1, M Ursula Norman, Tara Macrae, Paul R Mangan, Casey T Weaver, Daniel C Bullard, Donna-Marie McCafferty, Paul Kubes.   

Abstract

Lymphocyte localization to inflammatory sites is paramount for developing and maintaining an immune response. Rolling is the first step in recruitment, but our knowledge of its mechanisms in Th1 and Th2 CD4(+) lymphocytes is incomplete. Whereas initial studies suggested that Th1 but not Th2 lymphocytes used P-selectin for recruitment, more recent studies have proposed that both subtypes bind selectins. We used intravital microscopy to demonstrate in vivo that polarized Th1 and Th2 lymphocytes both use P-selectin to roll and adhere to cytokine [tumor necrosis factor (TNF)-alpha or interleukin (IL)-4]-activated intestinal microvasculature. The majority of Th1 lymphocyte flux in TNF-alpha- and IL-4-treated animals was P-selectin-dependent. Th1 lymphocytes also interacted with E-selectin to control rolling velocity after TNF-alpha stimulation. Th2 lymphocytes, which make IL-4 but not interferon-gamma, bound P-selectin ex vivo, with more than 95% rolling on P-selectin in vivo. Both Th1 and Th2 lymphocytes regulated rolling velocity by interacting with alpha(4)-integrin. Furthermore, in a model of spontaneous intestinal inflammation (ie, IL-10-deficient mice), both Th1 and Th2 lymphocytes rolled, adhered, and ultimately emigrated into the local microenvironment. These results suggest that both Th1 and Th2 lymphocytes use P-selectin in the initial rolling step in vivo in response to a global activator of the vasculature (TNF), a subtle inducer of P-selectin (IL-4), and pathological inflammation (IL-10-deficient mice).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314477      PMCID: PMC1613184          DOI: 10.1016/S0002-9440(10)61248-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  63 in total

1.  Tissue cytokine and chemokine expression in inflammatory bowel disease.

Authors:  G McCormack; D Moriarty; D P O'Donoghue; P A McCormick; K Sheahan; A W Baird
Journal:  Inflamm Res       Date:  2001-10       Impact factor: 4.575

2.  Expression of cutaneous lymphocyte-associated antigen on human CD4(+) and CD8(+) Th2 cells.

Authors:  M Akdis; S Klunker; M Schliz; K Blaser; C A Akdis
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

3.  Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis.

Authors:  K Tjandra; K A Sharkey; M G Swain
Journal:  Hepatology       Date:  2000-02       Impact factor: 17.425

4.  Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation.

Authors:  W W Agace; A I Roberts; L Wu; C Greineder; E C Ebert; C M Parker
Journal:  Eur J Immunol       Date:  2000-03       Impact factor: 5.532

5.  A CD2-green fluorescence protein-transgenic mouse reveals very late antigen-4-dependent CD8+ lymphocyte rolling in inflamed venules.

Authors:  K Singbartl; J Thatte; M L Smith; K Wethmar; K Day; K Ley
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

6.  A role for platelets and endothelial selectins in tumor necrosis factor-alpha-induced leukocyte recruitment in the brain microvasculature.

Authors:  J Carvalho-Tavares; M J Hickey; J Hutchison; J Michaud; I T Sutcliffe; P Kubes
Journal:  Circ Res       Date:  2000-12-08       Impact factor: 17.367

7.  Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine.

Authors:  P G Andres; P L Beck; E Mizoguchi; A Mizoguchi; A K Bhan; T Dawson; W A Kuziel; N Maeda; R P MacDermott; D K Podolsky; H C Reinecker
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

8.  Neutrophil tethering on E-selectin activates beta 2 integrin binding to ICAM-1 through a mitogen-activated protein kinase signal transduction pathway.

Authors:  S I Simon; Y Hu; D Vestweber; C W Smith
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

9.  T helper 1 and T helper 2 cells are pathogenic in an antigen-specific model of colitis.

Authors:  Nuzhat Iqbal; James R Oliver; Frederic H Wagner; Audrey S Lazenby; Charles O Elson; Casey T Weaver
Journal:  J Exp Med       Date:  2002-01-07       Impact factor: 14.307

10.  P-selectin and P-selectin glycoprotein ligand 1 are major determinants for Th1 cell recruitment to nonlymphoid effector sites in the intestinal lamina propria.

Authors:  Wael Haddad; Cristine J Cooper; Zheng Zhang; Jeffrey B Brown; Yuechun Zhu; Andrew Issekutz; Ivan Fuss; Hae-ock Lee; Geoffrey S Kansas; Terrence A Barrett
Journal:  J Exp Med       Date:  2003-07-28       Impact factor: 14.307

View more
  15 in total

1.  Oral administration of high molecular weight hyaluronan (900 kDa) controls immune system via Toll-like receptor 4 in the intestinal epithelium.

Authors:  Akira Asari; Tomoyuki Kanemitsu; Hitoshi Kurihara
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

2.  Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response.

Authors:  M Ursula Norman; John Hwang; Sara Hulliger; Claudine S Bonder; Jun Yamanouchi; Pere Santamaria; Paul Kubes
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

3.  Progenitor cells as remote "bioreactors": neuroprotection via modulation of the systemic inflammatory response.

Authors:  Peter A Walker; Phillip A Letourneau; Supinder Bedi; Shinil K Shah; Fernando Jimenez; Charles S Cox
Journal:  World J Stem Cells       Date:  2011-02-26       Impact factor: 5.326

4.  Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model.

Authors:  Ayumi Yoshizaki; Koichi Yanaba; Yohei Iwata; Kazuhiro Komura; Asako Ogawa; Yuichiro Akiyama; Eiji Muroi; Toshihide Hara; Fumihide Ogawa; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Thomas F Tedder; Shinichi Sato
Journal:  J Immunol       Date:  2010-07-12       Impact factor: 5.422

5.  Quantification and monitoring of inflammation in murine inflammatory bowel disease with targeted contrast-enhanced US.

Authors:  Nirupama Deshpande; Amelie M Lutz; Ying Ren; Kira Foygel; Lu Tian; Michel Schneider; Reetesh Pai; Pankaj J Pasricha; Jürgen K Willmann
Journal:  Radiology       Date:  2011-11-04       Impact factor: 11.105

6.  The A2B adenosine receptor protects against inflammation and excessive vascular adhesion.

Authors:  Dan Yang; Ying Zhang; Hao G Nguyen; Milka Koupenova; Anil K Chauhan; Maria Makitalo; Matthew R Jones; Cynthia St Hilaire; David C Seldin; Paul Toselli; Edward Lamperti; Barbara M Schreiber; Haralambos Gavras; Denisa D Wagner; Katya Ravid
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

Review 7.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

Review 8.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

9.  Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production.

Authors:  Krisztián Németh; Asada Leelahavanichkul; Peter S T Yuen; Balázs Mayer; Alissa Parmelee; Kent Doi; Pamela G Robey; Kantima Leelahavanichkul; Beverly H Koller; Jared M Brown; Xuzhen Hu; Ivett Jelinek; Robert A Star; Eva Mezey
Journal:  Nat Med       Date:  2008-11-21       Impact factor: 53.440

10.  Th1 Cells Rolling on Selectins Trigger DAP12-Dependent Signals That Activate Integrin αLβ2.

Authors:  Bojing Shao; Tadayuki Yago; Sumith R Panicker; Nan Zhang; Zhenghui Liu; Rodger P McEver
Journal:  J Immunol       Date:  2019-11-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.